Hongkong
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...
June 26, 2023 | News
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
The FDA provided Sirnaomics guidance to move forward with late-stage clinical development because of the efficacious data provided as well as the widesprea...
June 20, 2023 | News
Based on its SBDD strategy, Viva Biotech has achieved remarkable growth in its CRO drug discovery and development business through its continuous effort th...
June 16, 2023 | News
The Company's first GalAhead™-based RNAi drug candidate, STP122G, has started a Phase I clinical trial in May 2023. The start of the trial indic...
June 14, 2023 | News
HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...
June 13, 2023 | News
Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 at W Hong Kong, signing strategic partnership agreements with ...
June 12, 2023 | News
Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...
May 24, 2023 | News
- ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...
May 18, 2023 | News
The subsidy comes under HKSTP's Clinical Translational Catalyst ("CTC") programme dedicated to catalysing clinical translation to bring innovative, life-ch...
May 18, 2023 | News
"In just six months, we have submitted NDAs for XPOVIO® in three ASEAN countries, Malaysia, Thailand and Indonesia, supporting...
May 17, 2023 | News
The second International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC) and supported by a wide range of healthcare se...
May 04, 2023 | News
The system by Agilis Robotics offers a novel combination of features that set it apart from conventional surgical robotic systems. With a remarkably compac...
April 19, 2023 | News
Dr. Michael Shi, Head of R&D and Chief Medical Officer of HUTCHMED said, “The NMPA acceptance of our NDA for fruquintinib is a positive step towa...
April 18, 2023 | News
Most Read
Bio Jobs
News
Editor Picks